Literature DB >> 21183943

Pattern electroretinogram association with spectral domain-OCT structural measurements in glaucoma.

C Bowd1, A Tafreshi, L M Zangwill, F A Medeiros, P A Sample, R N Weinreb.   

Abstract

PURPOSE: To describe the association between pattern electroretinogram (PERG) amplitude and spectral domain-optical coherence tomography (SD-OCT) macular thickness, retinal nerve fibre layer (RNFL) thickness and optic disc topography measurements. SUBJECTS AND METHODS: Both eyes (n = 132) of 66 glaucoma patients (mean age = 67.9 years) enrolled in the University of California, San Diego, CA, USA, Diagnostic Innovations in Glaucoma Study (DIGS) were included. Eyes were tested with PERG (Glaid PERGLA, Lace Elettronica, Pisa, Italy), RTVue SD-OCT (Optovue Inc., Fremont, CA, USA) GCC, and NHM4 protocols on the same day. Of the 66 enrolled patients, 43 had glaucoma defined by repeated abnormal standard automated perimetry (SAP) results in at least one eye and 23 were glaucoma suspects defined by a glaucomatous-appearing optic disc by physicians' examination in at least one eye and normal SAP results in both eyes. Associations (R(2)) were determined between PERG amplitude (μV) and SD-OCT macular ganglion cell complex (GCC) thickness (μm), macular thickness (μm), macular outer retinal thickness (macular thickness minus GCC thickness) (μm), RNFL thickness (μm), neuroretinal rim area (mm(2)), and rim volume (mm(3)).
RESULTS: PERG amplitude was significantly associated with GCC thickness (R(2) = 0.179, P < 0.001), RNFL thickness (R(2) = 0.174, P < 0.001), and macular thickness (R(2) = 0.095, P<0.001). R(2) associations with other parameters were not significant (all P > 0.624). Significant associations remained for GCC and average RNFL thickness when age and intraocular pressure at the time of testing were included in multivariate models (both P ≤ 0.030).
CONCLUSIONS: PERG amplitude is significantly (but weakly) associated with macular GCC thickness, RNFL thickness, and macular thickness. The lack of association between PERG amplitude and macular outer retinal thickness supports previous results, possibly suggesting that that the PERG is driven primarily by retinal ganglion cell (inner retinal) responses.

Entities:  

Mesh:

Year:  2010        PMID: 21183943      PMCID: PMC3169218          DOI: 10.1038/eye.2010.203

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  31 in total

1.  The influence of ambient room lighting on the pattern electroretinogram (PERG).

Authors:  Michael Bach; Margret Schumacher
Journal:  Doc Ophthalmol       Date:  2002-11       Impact factor: 2.379

2.  Correlation between optical coherence tomography, pattern electroretinogram, and visual evoked potentials in open-angle glaucoma patients.

Authors:  V Parisi; G Manni; M Centofanti; S A Gandolfi; D Olzi; M G Bucci
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

3.  Effect of operator and optical defocus on the variability of pattern electroretinogram optimized for glaucoma detection (PERGLA).

Authors:  Gianmarco Vizzeri; Ali Tafreshi; Robert N Weinreb; Christopher Bowd
Journal:  J Glaucoma       Date:  2010-02       Impact factor: 2.503

Review 4.  Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer's disease.

Authors:  Vincenzo Parisi
Journal:  Semin Ophthalmol       Date:  2003-06       Impact factor: 1.975

5.  Retinal nerve fiber layer thickness and visual sensitivity using scanning laser polarimetry with variable and enhanced corneal compensation.

Authors:  Christopher Bowd; Ivan M Tavares; Felipe A Medeiros; Linda M Zangwill; Pamela A Sample; Robert N Weinreb
Journal:  Ophthalmology       Date:  2007-02-06       Impact factor: 12.079

6.  Relationship between electrophysiological, psychophysical, and anatomical measurements in glaucoma.

Authors:  David F Garway-Heath; Graham E Holder; Fred W Fitzke; Roger A Hitchings
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

7.  Reproducibility of RTVue retinal nerve fiber layer thickness and optic disc measurements and agreement with Stratus optical coherence tomography measurements.

Authors:  Alberto O González-García; Gianmarco Vizzeri; Christopher Bowd; Felipe A Medeiros; Linda M Zangwill; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2009-03-09       Impact factor: 5.258

8.  Relationship between pattern electroretinogram, standard automated perimetry, and optic nerve structural assessments.

Authors:  Mitra Sehi; Mariana Pinzon-Plazas; William J Feuer; David S Greenfield
Journal:  J Glaucoma       Date:  2009 Oct-Nov       Impact factor: 2.503

9.  Reproducibility of pattern electroretinogram in glaucoma patients with a range of severity of disease with the new glaucoma paradigm.

Authors:  Marie-Josée Fredette; Douglas R Anderson; Vittorio Porciatti; William Feuer
Journal:  Ophthalmology       Date:  2007-11-05       Impact factor: 12.079

10.  Repeatability of pattern electroretinogram measurements using a new paradigm optimized for glaucoma detection.

Authors:  Christopher Bowd; Ali Tafreshi; Gianmarco Vizzeri; Linda M Zangwill; Pamela A Sample; Robert N Weinreb
Journal:  J Glaucoma       Date:  2009-08       Impact factor: 2.503

View more
  19 in total

1.  Pattern electroretinogram progression in glaucoma suspects.

Authors:  Lori M Ventura; Iuri Golubev; William J Feuer; Vittorio Porciatti
Journal:  J Glaucoma       Date:  2013-03       Impact factor: 2.503

2.  A study of retinal parameters measured by optical coherence tomography in patients with multiple sclerosis.

Authors:  Sai-Jing Hu; Yi-An You; Yi Zhang
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

3.  Pattern electroretinogram to detect glaucoma: comparing the PERGLA and the PERG Ratio protocols.

Authors:  Michael Bach; Anke Ramharter-Sereinig
Journal:  Doc Ophthalmol       Date:  2013-10-15       Impact factor: 2.379

4.  Structural and functional changes in glaucoma: comparing the two-flash multifocal electroretinogram to optical coherence tomography and visual fields.

Authors:  Anna A Ledolter; Matthias Monhart; Andreas Schoetzau; Margarita G Todorova; Anja M Palmowski-Wolfe
Journal:  Doc Ophthalmol       Date:  2015-01-24       Impact factor: 2.379

5.  Assessment of macular function of glaucomatous eyes by multifocal electroretinograms.

Authors:  Nobuhide Hori; Shinya Komori; Hiroki Yamada; Akira Sawada; Yasunori Nomura; Kiyofumi Mochizuki; Tetsuya Yamamoto
Journal:  Doc Ophthalmol       Date:  2012-09-04       Impact factor: 2.379

6.  Correlation between multifocal pattern electroretinography and Fourier-domain OCT in eyes with temporal hemianopia from chiasmal compression.

Authors:  Mário L R Monteiro; Kenzo Hokazono; Leonardo P Cunha; Maria K Oyamada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-29       Impact factor: 3.117

7.  Relation between macular retinal ganglion cell/inner plexiform layer thickness and multifocal electroretinogram measures in experimental glaucoma.

Authors:  Xunda Luo; Nimesh B Patel; Lakshmi P Rajagopalan; Ronald S Harwerth; Laura J Frishman
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-26       Impact factor: 4.799

8.  Efficacy of N95 amplitude of pattern electroretinogram measured from baseline to N95 trough in the traumatic optic neuropathy.

Authors:  Kun Hae Kim; Ungsoo Samuel Kim
Journal:  Jpn J Ophthalmol       Date:  2019-03-08       Impact factor: 2.447

9.  Progressive loss of retinal ganglion cell function precedes structural loss by several years in glaucoma suspects.

Authors:  Michael R Banitt; Lori M Ventura; William J Feuer; Eleonore Savatovsky; Gabriel Luna; Olga Shif; Brandon Bosse; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-28       Impact factor: 4.799

10.  Ganglion cell loss in early glaucoma, as assessed by photopic negative response, pattern electroretinogram, and spectral-domain optical coherence tomography.

Authors:  Barbara Cvenkel; Maja Sustar; Darko Perovšek
Journal:  Doc Ophthalmol       Date:  2017-05-31       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.